DEFA14A: CareCloud Seeks Shareholder Approval for Increased Authorized Shares to Fuel Growth

CareCloud is soliciting proxies to increase its authorized shares from 35 million to 85 million to support growth initiatives and potential conversion of preferred stock.

Summary

• CareCloud is seeking shareholder approval to increase its authorized common stock from 35 million to 85 million shares.
• The company intends to use the additional shares for strategic growth initiatives, including potential acquisitions and conversion of Series A Preferred Stock.
• CareCloud has experienced a 23% compound annual growth rate (CAGR) over the past decade through acquisitions and organic growth.
• In the first three quarters of 2024, CareCloud generated over $10 million in free cash flow and achieved a 50% year-over-year increase in adjusted EBITDA.
• A special meeting of shareholders is scheduled for January 27, 2025, to vote on the proposal.

Sentiment

Score: 7

Explanation: The document conveys a positive outlook with strong growth metrics and strategic plans, but also acknowledges risks and uncertainties. The proposed share increase is a common growth strategy.

Positives

• CareCloud has demonstrated strong growth with a 23% CAGR over the past decade.
• The company has generated over $10 million in free cash flow in the first three quarters of 2024.
• CareCloud achieved a 50% year-over-year increase in adjusted EBITDA in the first three quarters of 2024.
• The proposed increase in authorized shares is intended to support strategic growth initiatives and potential acquisitions.
• The company's board and executive team collectively own more than 38% of the common stock, indicating strong alignment with shareholder interests.

Risks

• The company's ability to manage growth, integrate acquisitions, and retain customers are key risks.
• Changes in reimbursement and industry regulations could impact the company's performance.
• The company faces competition from other companies in the healthcare technology sector.
• The company's ability to develop new technologies and adapt to evolving industry standards is crucial for future success.

Future Outlook

The company aims to achieve sustained, double-digit growth with a focus on profitability, supported by the proposed increase in authorized shares.

Management Comments

• Mahmud Haq, Founder and Executive Chairman, stated that increasing the number of authorized shares is essential to driving revenue and profits.
• Management believes the increase in authorized shares will empower the company to deliver sustained, double-digit growth with a focus on profitability.

Industry Context

The announcement reflects a trend in the healthcare technology sector where companies seek capital to fund growth and acquisitions. CareCloud's focus on AI and technology solutions aligns with the industry's move towards digital transformation.

Comparison to Industry Standards

• CareCloud's 23% CAGR over the past decade is strong compared to many established healthcare technology companies, but specific comparisons would require a deeper dive into peer performance.
• The 50% year-over-year increase in adjusted EBITDA is a positive sign, but it's important to compare this to industry benchmarks and competitors like athenahealth, NextGen Healthcare, and eClinicalWorks to assess its relative strength.
• The proposed increase in authorized shares is a common strategy for growth-oriented companies, but its effectiveness will depend on how well CareCloud executes its strategic initiatives.

Stakeholder Impact

• Shareholders will have the opportunity to vote on the proposed increase in authorized shares.
• The company's growth initiatives are intended to benefit shareholders through increased value.
• The company's focus on profitability is intended to benefit shareholders through improved financial performance.
• The company's growth plans may lead to increased employment opportunities.

Next Steps

• Shareholders will vote on the proposal to increase authorized shares at the special meeting on January 27, 2025.
• The company will continue to pursue strategic growth initiatives, including potential acquisitions.
• CareCloud will focus on converting its outstanding Series A Preferred Stock to Common Stock.

Key Dates

Keywords

authorized shares, proxy, healthcare technology, growth, acquisitions, EBITDA, free cash flow, shareholders, common stock, preferred stock